Ad Stars: MicroMass (Fosrenol)
GAME ON
agency: MicroMass Communications
brand: Fosrenol
client: Shire
photo from left: Jessica Brueggeman, senior behaviorist • Kim Levy, VP, strategic planning • Carl Malpass, VP, group account director • Bill Leinhos, director, dialysis clinics, Fosrenol, Shire • Jamie Cobb, executive creative director
When MicroMass was contracted to market Shire's Fosrenol, the drug, which lowers elevated blood phosphate levels, was third in its category. Rather than pelting overburdened docs with even more messages, the agency focused on an underleveraged audience in the space—patients.
The creative team developed a patient-education program using branded board games, cookbooks, crossword puzzles, and word searches, and made them available to patients receiving dialysis treatment at the clinics."For patients, the dialysis clinic is like a home away from home," says Jamie Cobb of MicroMass. "And so the whole idea of supporting each other and developing a community feel was a big underlying insight that fed into the creative."
The games were an innovative vehicle that enabled health-literate communications by keeping it simple—and at the same time, educating patients about this chronic and complicated disease.
PREVIOUS AGENCY ‹‹ HOME ›› NEXT AGENCY
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
